Search research articles
Contact Us
Filters
Showing results (201-210 of 210) with videos related to
Page
of 21
Sort By:
You have reached the last page of results.
This site can display upto 210 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 4, 2014
Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer
F Rothé, J-F Laes, D Lambrechts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2004
Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study
D Schrijvers, C Van Herpen, J Kerger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 10, 2013
Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial
E de Azambuja, D Zardavas, M Lemort, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 9, 2022
Streamlining clinical research: an ESMO awareness call to improve sponsoring and monitoring of clinical trials
J L Perez-Gracia, N Penel, E Calvo, et al.
ESMO Open
|
April 9, 2025
Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma
U M Lauer, A Awada, S Postel-Vinay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2013
Present and future breast cancer management--bench to bedside and back: a positioning paper of academia, regulatory authorities and pharmaceutical industry
R Bartsch, S Frings, M Marty, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2018
Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study
S Adams, P Schmid, H S Rugo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 28, 2017
Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study
A Psyrri, C Fortpied, G Koutsodontis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2015
Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial
G Gebhart, L E Lamberts, Z Wimana, et al.
ESMO Open
|
August 15, 2022
PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment
J Thouvenin, C Van Marcke, L Decoster, et al.
Page
of 21
Search research articles
Search
Showing results (201-210 of 210) with videos related to
Sort By:
Page
of 21
You have reached the last page of results.
This site can display upto 210 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 4, 2014
Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer
F Rothé, J-F Laes, D Lambrechts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2004
Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study
D Schrijvers, C Van Herpen, J Kerger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 10, 2013
Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial
E de Azambuja, D Zardavas, M Lemort, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 9, 2022
Streamlining clinical research: an ESMO awareness call to improve sponsoring and monitoring of clinical trials
J L Perez-Gracia, N Penel, E Calvo, et al.
ESMO Open
|
April 9, 2025
Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma
U M Lauer, A Awada, S Postel-Vinay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2013
Present and future breast cancer management--bench to bedside and back: a positioning paper of academia, regulatory authorities and pharmaceutical industry
R Bartsch, S Frings, M Marty, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2018
Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study
S Adams, P Schmid, H S Rugo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 28, 2017
Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study
A Psyrri, C Fortpied, G Koutsodontis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2015
Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial
G Gebhart, L E Lamberts, Z Wimana, et al.
ESMO Open
|
August 15, 2022
PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment
J Thouvenin, C Van Marcke, L Decoster, et al.
Page
of 21